Sutro Biopharma (STRO) Asset Utilization Ratio (2018 - 2026)

Sutro Biopharma has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.51 in Q4 2025.

• Quarterly Asset Utilization Ratio rose 243.61% year-over-year to 0.51 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.51 (up 243.61% YoY) and the FY2025 annual result came in at 0.37, up 152.6% from the prior year.
• Asset Utilization Ratio climbed to 0.51 in Q4 2025 per STRO's latest filing, from 0.45 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.51 in Q4 2025 and troughed at 0.11 in Q3 2023.
• A 5-year average of 0.24 and a median of 0.18 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio plunged 56.59% in 2024, then jumped 243.61% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.17 in 2021, then declined by 3.33% to 0.17 in 2022, then surged by 103.0% to 0.34 in 2023, then slumped by 56.59% to 0.15 in 2024, then surged by 243.61% to 0.51 in 2025.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.51, 0.45, and 0.36 for Q4 2025, Q3 2025, and Q2 2025 respectively.